New York 2023-2024 Regular Session

New York Senate Bill S01196

Introduced
1/10/23  
Refer
1/10/23  
Report Pass
5/22/23  
Engrossed
6/5/23  
Refer
6/5/23  
Engrossed
6/8/23  
Enrolled
12/12/23  
Chaptered
12/22/23  

Caption

Requires health insurance policies and medicaid to cover biomarker testing for diagnosis, treatment, appropriate management, or ongoing monitoring of a covered person's disease or condition when the test is supported by medical and scientific evidence.

Companion Bills

NY A01673

Same As Requires health insurance policies and medicaid to cover biomarker testing for diagnosis, treatment, appropriate management, or ongoing monitoring of a covered person's disease or condition when the test is supported by medical and scientific evidence.

Previously Filed As

NY A01673

Requires health insurance policies and medicaid to cover biomarker testing for diagnosis, treatment, appropriate management, or ongoing monitoring of a covered person's disease or condition when the test is supported by medical and scientific evidence.

NY HB85

Insurance; require health benefit policy coverage for biomarker testing if supported by medical and scientific evidence

NY HB659

Insurance; health benefit policy coverage for biomarker testing if supported by medical and scientific evidence; require

NY SB513

Biomarker testing; requiring health insurance coverage of biomarker testing under certain conditions. Effective date.

NY SB513

Biomarker testing; requiring health insurance coverage of biomarker testing under certain conditions. Effective date.

NY H0805

Health Insurance Coverage for Biomarker Testing

NY HB24

Require health plan and Medicaid coverage of biomarker testing

NY HB8

Require health plan and Medicaid coverage of biomarker testing

NY SB104

Provides for health insurance coverage of genetic testing for diseases and other medical conditions. (8/1/23) (EN INCREASE GF EX See Note)

NY S2201

Accident And Sickness Insurance Policies -- Biomarker Testing Coverage

Similar Bills

No similar bills found.